HealthEquity appoints two senior executives amid HSA expansion

DRAPER, Utah - HealthEquity, Inc. (NASDAQ:HQY), the nation’s largest Health Savings Account (HSA) administrator and an $8.1 billion market cap company with a "GREAT" financial health rating according to InvestingPro, announced Thursday the appointment of two senior executives to its leadership team as the company prepares for upcoming HSA eligibility expansion.

Mukund Ramachandran will join as Chief Marketing Officer and Garett Kitch as Senior Vice President of Client Sales & Relationship Management, both effective September 29, 2025.

The appointments come as HealthEquity positions itself to capitalize on recent federal legislation that will expand HSA eligibility beginning January 1, 2026. The legislation will allow Direct Primary Care arrangements, low-cost telehealth services, and all individual Bronze and Catastrophic Affordable Care Act plans to be paired with HSAs. The company’s strong positioning is reflected in its impressive 15.45% revenue growth and perfect Piotroski Score of 9, as reported by InvestingPro.

Ramachandran brings over 25 years of B2B marketing experience, most recently serving as SVP, Head of B2B Marketing for Commercial & New Payment Flows at Mastercard. In his new role, he will develop HealthEquity’s enterprise-wide marketing strategy and oversee brand engagement across B2B and B2C audiences.

Kitch joins with two decades of experience in sales leadership. He previously served as Chief Sales Officer at EverQuote and held leadership roles at eHealth, Inc., where he managed teams responsible for $420 million in revenue. At HealthEquity, he will implement sales strategies focused on organic growth and new client acquisition.

Both executives will report to Michael Fiore, Chief Commercial Officer.

The company stated that approximately 90% of Bronze plans were previously ineligible for HSAs, representing a significant market expansion opportunity. HealthEquity currently administers more than 17 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers, according to the press release statement. With eight analysts recently revising their earnings estimates upward and a healthy current ratio of 4.23, the company appears well-positioned for this expansion. For detailed analysis and additional insights, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers this and 1,400+ other top US stocks.

In other recent news, HealthEquity Inc. reported robust financial results for the second quarter of fiscal year 2026. The company exceeded analyst expectations with earnings per share (EPS) of $1.08, compared to the projected $0.92. Revenue for the quarter also surpassed forecasts, reaching $325.9 million against the anticipated $320.74 million. These results indicate a strong performance for HealthEquity, drawing attention from investors. The earnings announcement was followed by a notable increase in the company’s stock price, although specific stock movements are not discussed here. Such financial achievements highlight the company’s effective strategies and operational strength. Investors and analysts will likely keep a close watch on HealthEquity’s future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.